Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 24, 2026

Back to today

Tower Semiconductor Deep Dive

Tower Semiconductor’s low-loss photonics chips halve lasers in 1.6T optical modules, supporting a $680 million annualized photonics run rate and customer wafer prepayments through 2027.

TSEM $19B
CV's Substack 5 clicks

From X

@StableBread 4 clicks

Fajasy on X

Here’s where BWX Technologies’ $BWXT stock could be by the end of 2027, 15 months from now, in my bear, base, and bull cases. I value each case on 2028 adjusted EBITDA, since the market will be pricing 2028 numbers by then. For net debt, I use today’s $1.65B minus the $750M from its medical isotope sale, or $0.9B. To stay conservative, I don’t credit the FCF $BWXT earns between now and the end of 2027. Management plans to spend the cash, including on acquisitions, but hasn’t said how much or on what, so I leave out both the cash and any EBITDA acquisitions could potentially add. Therefore, each case’s value is 2028 adjusted EBITDA times the multiple, minus the $0.9B of net debt, over 92.0M diluted shares (its convertible notes only dilute above $262.51). Bear case ($118, -19%) The bear case assumes budgets slip (the government is running on a continuing resolution through December 11), the terms of its Janus contract (the Army’s microreactor program for military bases) disappoint, and new-build orders arrive later than John MacQuarrie, president of Commercial Operations, expects. That implies only 5%/year adjusted EBITDA growth to $735M in 2028, and a multiple of 16x, slightly below $BWXT’s 16.6x at the end of 2023, for a value of $118/share. Base case ($162, +11%, most likely) The base case assumes $BWXT delivers its 2027 framework (high-single-digit growth to $720M of adjusted EBITDA) and grows 10% in 2028 to $790M as new-build revenue starts. That implies the multiple holds at 20x, near today’s, for a value of $162/share. $BWXT’s own 2030 plan goes further. Today’s $15.0B EV is 13.0x the $1.15B midpoint of its 2030 adjusted EBITDA target. If $BWXT hits that midpoint, trades at 18x instead of the base case’s 20x, and runs at 2.5x net leverage (~$2.9B of net debt) after deploying its capital, the stock would be worth $194/share at the end of 2029. With ~$4/share of total dividends through 2029, that’s a 9.9%/year return from $145.70. But getting from the base case’s $790M in 2028 to $1.15B in 2030 takes ~21%/year growth, more than double the 2028 pace, so the new orders and acquisitions outside $BWXT’s predictable core (the programs backed by backlog and long-term contracts) have to show up. Bull case ($204, +40%) The bull case assumes a new-build order lands by early 2027, $BWXT signs a Janus contract on par with microreactor startup Radiant’s (up to $750M), and margins rise toward 20%. That implies adjusted EBITDA of $820M in 2028 and a re-rating to 24x, just under the 24.8x of Curtiss-Wright $CW today, for a value of $204/share. Notably, none of the three cases considers a commercial BANR (microreactor) sale, a Wyoming TRISO fuel plant, a battleship reactor, or a data center customer, so at $145.70/share, you’re getting commercial microreactors and data centers as a free option.
@StableBread 1 click

Fajasy on X

Here’s what Boost Run $BRUN has already committed to pay, and what it still has to finance in H2 2026. $BRUN’s GPUs need space and power, which it rents in other companies’ data centers (colocation). The four leases signed since April already cover the space and power for the year-end deployments, and CEO Andrew Karos said its partnerships now reach 253 MW of power. $BRUN owes the rent on those sites whether or not the GPUs get financed. In 2027, the commitments $BRUN has already signed call for ~$221M of payments, including $103.5M on its GPU leases, $28.9M of rent on the sites in use as of June 30, ~$69M on the four new leases, and $20M for software. $BRUN’s $191.8M of pro forma cash and $93.6M of contracted prepayments, $285.4M together, cover the ~$221M of 2027 payments before counting any monthly billings from customers. But the same cash also pays $BRUN’s share of the H2 2026 build, so its monthly billings will have to cover part of the 2027 payments. To reach the $1.0-1.2B of GPU spending management expects for 2026, $BRUN has to deploy $663-863M of GPU servers in H2 2026, 2.3-3.0x its cash and contracted prepayments. If lessors fund 79.5% of the H2 2026 build, as they did in H1 2026, $BRUN needs $527-686M of new leases, 2.2-2.9x the $238.1M the company owed on finance leases as of June 30. The other $136-176M would be paid in cash. The $527-686M works out to $264-343M/quarter on average across Q3 and Q4, 1.3-1.6x the $208.2M of leases $BRUN took on in Q2. $BRUN’s lease debt would rise by less than the $527-686M, since the company keeps paying down its leases while adding new ones. During H1 2026, its finance lease debt rose $207.7M on $337.3M of new GPU equipment, or 61.6%, which for H2 2026 would imply ~$410-530M more debt. New leases will likely cost more than ~7% after the rise in rates. For context, at the 9.0% $IREN agreed to pay on its August GPU financing, the extra interest on $527-686M would be ~$6.5-8.5M/year, 1.6-2.1% of the $400M ARR target. And $BRUN isn’t slowing down. By June 30, the company had already placed orders well above the $578M first-year minimum in its April 2026 agreement with Dell $DELL, which also requires at least $215.5M/year of Dell equipment from April 2027 to April 2031 or a payment for the shortfall.

Investor Letters

All letters

Margin Call

Petrobras’s Morpho-1 well revived hopes that Brazil’s Equatorial Margin can become a major new oil frontier after hydrocarbons were…

PBR $96B
Doomberg 5 clicks

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $34B
WHAT ARE WE DOING? “Contrarians At The Gate” 10 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $34B
Net Interest 8 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B
Best Anchor Stocks 12 clicks
CLF · long

Cleveland-cliffs INC

Cleveland-Cliffs is pitched as a long on underappreciated earnings power, with more than 90% return potential over six to nine months.

CLF $7.8B
Value Investors Club

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 33 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 61 of 249

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.